BioCentury
ARTICLE | Financial News

Aeglea prices $12.3M follow-on

June 16, 2017 5:08 AM UTC

On June 6, enzyme therapy company Aeglea BioTherapeutics Inc. (NASDAQ:AGLE) raised $12.3 million through the sale of 3 million shares at $4.10 in a follow-on underwritten by JonesTrading Institutiona...

BCIQ Company Profiles

Aeglea BioTherapeutics Inc.